Seonix Bio
1 known investors
Find your way into Seonix Bio
73 people in our graph share verified history with the Seonix Bio team — schools, employers, funds. One of them is your warm intro.
Tom Skevingtonunlockedknows Jamie Craig · together at University of Adelaide
×11knows the team · via University of Adelaide
Seonix develops a genetic risk score to identify individuals at elevated risk of glaucoma, serving eye health professionals, patients, and researchers. The company uses large-scale genetic datasets and advanced techniques for clinical risk prediction to help prevent vision loss.
Founders & leadership
JM
Johnathon MatthewsinCo-Founder
JC
Jamie CraiginCo-FounderJamie Craig is Chair and Academic Head of Ophthalmology at Flinders University and a Consultant Ophthalmologist with expertise in glaucoma genetics and clinical translation. He founded the Australian and New Zealand Registry of Advanced Glaucoma and leads research on genetic susceptibility to glaucoma and other eye diseases, including genome-wide association studies to identify genes linked to glaucoma risk.
AH
Alex HewittCo-Founder
N
NickChief Executive Officer
Investors · 1
In the news
Frequently asked questions
- What does Seonix Bio do?
- Seonix develops a genetic risk score to identify individuals at elevated risk of glaucoma, serving eye health professionals, patients, and researchers. The company uses large-scale genetic datasets and advanced techniques for clinical risk prediction to help prevent vision loss.
- Who founded Seonix Bio?
- Seonix Bio was founded by Johnathon Matthews, Jamie Craig, Alex Hewitt.
- Who are Seonix Bio's investors?
- Seonix Bio's investors include South Australian Venture Capital Fund.